Home › Funds › Diamond Hill Capital Management, LLC (Investment Advisor) › LH

Diamond Hill Capital Management, LLC (Investment Advisor) position in LH

LABCORP HOLDINGS INC · Health Care

Diamond Hill Capital Management, LLC (Investment Advisor) reported holding 449,901 shares of LH (LABCORP HOLDINGS INC) in its Q3 2026 13F filing — a position valued at US$138.6M, representing 1.51% of its reported portfolio and ranking #25 among its reported holdings. Diamond Hill Capital Management, LLC (Investment Advisor) has disclosed LH holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)449.90K sh
Reported value held$138.62M
Portfolio Weight1.51%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Diamond Hill Capital Management, LLC (Investment Advisor)'s LH position evolved

Diamond Hill Capital Management, LLC (Investment Advisor) first disclosed a stake in LH in Q3 2023 at 1,280,884 shares (US$257.5M). The position peaked in Q2 2025 at 1,823,506 shares, worth US$478.7M. Across 13 filings, Diamond Hill Capital Management, LLC (Investment Advisor) increased the stake 4 time(s), trimmed it 8 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 449,901 shares valued at US$138.6M — a reduction of -150,891 shares quarter over quarter.. Notable position changes include a 25% increase in Q2 2024 (shares rose 10% over the following quarter), a 39% trim in Q1 2026 (shares rose 5% over the following quarter), a 25% trim in Q3 2026 (shares rose 20% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.28M $257.52M New
Q4 2023 1.42M $323.63M Add
Q1 2024 1.55M $339.58M Add
Q2 2024 1.95M $396.77M Add
Q3 2024 1.98M $442.20M Add
Q4 2024 1.97M $451.10M Reduce
Q1 2025 1.95M $454.21M Reduce
Q2 2025 1.82M $478.69M Reduce
Q3 2025 1.64M $471.42M Reduce
Q4 2025 1.26M $316.14M Reduce
Q1 2026 764.27K $203.91M Reduce
Q2 2026 600.79K $168.22M Reduce
Q3 2026 449.90K $138.62M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About LH and 13F data

LH (LABCORP HOLDINGS INC) is a Health Care company. 27 other funds we track also report a position in LH — the largest reported positions include VICTORY CAPITAL MANAGEMENT INC (US$1.21B), Boston Partners (US$908.7M), Allspring Global Investments Holdings, LLC (US$632.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding LH

All LH fund holders →

FAQ

How long has Diamond Hill Capital Management, LLC (Investment Advisor) held LH?

Diamond Hill Capital Management, LLC (Investment Advisor) has disclosed LH holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Diamond Hill Capital Management, LLC (Investment Advisor)'s current position in LH?

As of Q3 2026, Diamond Hill Capital Management, LLC (Investment Advisor) holds 449.90K shares of LH (LABCORP HOLDINGS INC), valued at $138.62M, representing 1.51% of its reported portfolio and ranking #25.

Has Diamond Hill Capital Management, LLC (Investment Advisor) been buying or selling LH?

In the latest 13F filing (Q3 2026), Diamond Hill Capital Management, LLC (Investment Advisor) reduced its position in LH. The position peaked in Q2 2025 at 1.82M shares.

Which other funds hold LH?

Other major institutional holders of LH include VICTORY CAPITAL MANAGEMENT INC, Boston Partners, Allspring Global Investments Holdings, LLC, among 27 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.